The IV Equipment Market features a well-established and competitively active group of global intravenous therapy device and consumable leaders, and this IV Equipment Market Competitive Landscape analysis reveals how their safety catheter product launches, ultramodern manufacturing facility investments, AI-powered smart pump developments, and geographic market expansions are collectively advancing the clinical safety and technological frontier of IV therapy delivery. The market's projected expansion from US$ 16.94 billion in 2025 to US$ 27.88 billion by 2033 drives sustained competitive investment across all IV equipment product categories.
Request Sample Pages of this Research Study @ https://www.businessmarketinsights.com/sample/BMIPUB00032617
Key Market Players
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Baxter International
- Terumo Corporation
- ICU Medical
- Fresenius Kabi
- AngioDynamics
- Moog Inc.
- Nipro Corporation
- Medtronic
IV Equipment Market Drivers and Opportunities:
Increasing Prevalence of Chronic Diseases
Increasing burden of chronic diseases, significantly increases the demand for intravenous therapies relying on specialized equipment such as infusion pumps, IV catheters, and administration sets. Chronic diseases, including cardiovascular diseases, diabetes, and cancer, often require repeated or long-term fluid, medication, and nutritional infusions as part of a regimen of treatment protocols. Because intravenous therapy remains a mainstay of patient care globally, many industry analyses demonstrate that as the incidence of these non-communicative diseases increases, so too does healthcare utilization and the need for reliable IV delivery systems; for instance, it is demonstrated that 71% of global deaths are due to chronic diseases, indicating an ever-expanding population reliant on such therapies. Moreover, with an aging population, the prevalence of age-related chronic conditions further amplifies this effect, resulting in continued demand for IV equipment within both hospitals, clinics, and home healthcare settings. It is expected that new or enhanced IV technologies will fuel demand, hence underlining the leading role of chronic disease as a factor in market growth.
Rapid Expansion of Home-Based Healthcare Services and Smart Infusion Technologies
Home-based healthcare service and smart infusion technology activation is the result of changing the care delivery models and technology innovation. Portable and easy-to-use IV devices are becoming a necessity with hospitals in demand for smart infusion pumps that not only connect with the digital platforms but also with electronic health records (EHRs) and remote monitoring systems. For instance, almost half of the hospitals, i.e., 46%, are going for the adoption of smart infusion pumps worldwide; thus, these connected devices that are lowering medication errors and improving safety are becoming a trend more and more prevalent. To date, AI-powered smart pumps from the likes of B. Braun whose main feature is real-time monitoring and improved safety have been the latest technological rollouts; this is vividly showing how innovation is not only bringing about new product categories but also new revenue streams. Expansion of home infusion therapy options partnered with telehealth and remote patient management is resulting in higher usage of small IV systems outside hospitals. All these trends open a strong window for the makers to grow by innovating and developing sophisticated, connected IV equipment that is suited for home care and digital healthcare systems simultaneously.
About Us
Business Market Insights is a one-stop industry research provider of actionable intelligence. Specializing in industries including Manufacturing and Construction, Semiconductor and Electronics, Healthcare, and more, the firm publishes over 500 research reports annually.
Contact Us
If you have any queries about this report or if you would like further information, please contact us: Phone: +16467917070 E-mail: sales@businessmarketinsights.com
